Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca
type: MedicalStudy
description: A Phase II Study of Allogeneic Large Multivalent Immunogen (LMI) Vaccine and IL-2 for the Treatment of Stable Metastatic Breast Cancer
status: TERMINATED
study design: INTERVENTIONAL
phase: PHASE2
start date: 2008-09
end date: 2014-07
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT00784524
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Masonic Cancer Center, University of Minnesota
study subject: Breast Cancer
keywords: PHASE2
keywords: INTERVENTIONAL
keywords: TERMINATED
keywords: Breast Cancer

AI Analytics
type: Organization